| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |